| Product NDC: | 0187-0771 |
| Proprietary Name: | Cardizem |
| Non Proprietary Name: | Diltiazem Hydrochloride |
| Active Ingredient(s): | 30 mg/1 & nbsp; Diltiazem Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-0771 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018602 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101225 |
| Package NDC: | 0187-0771-47 |
| Package Description: | 100 TABLET, COATED in 1 BOTTLE (0187-0771-47) |
| NDC Code | 0187-0771-47 |
| Proprietary Name | Cardizem |
| Package Description | 100 TABLET, COATED in 1 BOTTLE (0187-0771-47) |
| Product NDC | 0187-0771 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Diltiazem Hydrochloride |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20101225 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |